1.
Haematologica
; 108(12): 3460-3463, 2023 Dec 01.
Article
En
| MEDLINE
| ID: mdl-37345485
Idarubicin , Leukemia, Myeloid, Acute , Humans , Idarubicin/adverse effects , Cytarabine/adverse effects , Leukemia, Myeloid, Acute/drug therapy , Leukemia, Myeloid, Acute/genetics , Staurosporine/pharmacology , Antineoplastic Combined Chemotherapy Protocols/adverse effects , fms-Like Tyrosine Kinase 3/genetics , Mutation , Remission Induction